Abstract
Diabetes mellitus, an epidemic metabolic disorders characterized by high blood glucose level associated with various macrovascular and microvascular complications, is one of the main causes of human suffering across the globe. Researchers around the world mainly focused on insulin, insulin analogues, oral hypoglycemic agents and various other complementary and alternate medicines to control the blood glucose levels in diabetes. The present review summarizes the disorders associated with elevation of blood glucose level, biochemical & endocrinological aspects and the current strategies to control. The emphasis has been laid in particular on the new potential biological targets and the possible treatment as well as the current ongoing research status on new generation hypoglycemic agents.
Keywords: Diabetes, insulin, carbohydrate metabolism, sulfonylurea, thiazolidindione, carbohydrate, lipids, lipoprotein, hyperglycemia, nephropathy, retinopathy, neuropathy, T1DM, T2DM, GDM, Cystic Fibrosis, Cushing's syndrome, MHC, TH, NK, CD8, CD4, Genetic Factors, Down's syndrome, fibrinolysis, free fatty acids, glucose, Lipid Metabolism, ketone bodies, VLDL, Glucagon, Catecholamines, Growth Hormone, Glucocorticoids, DNA, Cytokines, NOS, KATP, SUR, ATP, Biguanides, Meglitinide Analogues, Thiazolidindiones, Ocimum santum, antioxidant activity, Allicin, Leucodelphinidine, Charantin, Bumelia sartorum, glycogenolysis, PPAR, GLP-1, LA, IKK, Mifepristone, DPP IV, Amylin Analog, PTP 1B, PTPase, OBA, TC-PTP
Current Medicinal Chemistry
Title: Pharmacology and Chemistry of Diabetes mellitus and Antidiabetic Drugs: A Critical Review
Volume: 17 Issue: 35
Author(s): Ganesh R. Kokil, Prarthana V. Rewatkar, Arunima Verma, Suresh Thareja and Suresh R. Naik
Affiliation:
Keywords: Diabetes, insulin, carbohydrate metabolism, sulfonylurea, thiazolidindione, carbohydrate, lipids, lipoprotein, hyperglycemia, nephropathy, retinopathy, neuropathy, T1DM, T2DM, GDM, Cystic Fibrosis, Cushing's syndrome, MHC, TH, NK, CD8, CD4, Genetic Factors, Down's syndrome, fibrinolysis, free fatty acids, glucose, Lipid Metabolism, ketone bodies, VLDL, Glucagon, Catecholamines, Growth Hormone, Glucocorticoids, DNA, Cytokines, NOS, KATP, SUR, ATP, Biguanides, Meglitinide Analogues, Thiazolidindiones, Ocimum santum, antioxidant activity, Allicin, Leucodelphinidine, Charantin, Bumelia sartorum, glycogenolysis, PPAR, GLP-1, LA, IKK, Mifepristone, DPP IV, Amylin Analog, PTP 1B, PTPase, OBA, TC-PTP
Abstract: Diabetes mellitus, an epidemic metabolic disorders characterized by high blood glucose level associated with various macrovascular and microvascular complications, is one of the main causes of human suffering across the globe. Researchers around the world mainly focused on insulin, insulin analogues, oral hypoglycemic agents and various other complementary and alternate medicines to control the blood glucose levels in diabetes. The present review summarizes the disorders associated with elevation of blood glucose level, biochemical & endocrinological aspects and the current strategies to control. The emphasis has been laid in particular on the new potential biological targets and the possible treatment as well as the current ongoing research status on new generation hypoglycemic agents.
Export Options
About this article
Cite this article as:
R. Kokil Ganesh, V. Rewatkar Prarthana, Verma Arunima, Thareja Suresh and R. Naik Suresh, Pharmacology and Chemistry of Diabetes mellitus and Antidiabetic Drugs: A Critical Review, Current Medicinal Chemistry 2010; 17 (35) . https://dx.doi.org/10.2174/092986710793361225
DOI https://dx.doi.org/10.2174/092986710793361225 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Chemical and Genetic Engineering Strategies to Improve the Potency of Pharmaceutical Proteins and Enzymes
Current Medicinal Chemistry Mediterranean Diet Rich in Olive Oil and Obesity, Metabolic Syndrome and Diabetes Mellitus
Current Pharmaceutical Design Calcium Channel Blockers in Restoration of Endothelial Function: Systematic Review and Meta-Analysis of Randomized Controlled Trials
Current Medicinal Chemistry Hydrogels Based on Interpenetrating Network of Chitosan and Polyvinyl Pyrrolidone for pH-Sensitive Delivery of Repaglinide
Current Drug Discovery Technologies Mechanisms of Renal Microvascular Dysfunction in Type 1 Diabetes: Potential Contribution to End Organ Damage
Current Vascular Pharmacology Application in Electrochemistry of Graphene-Modified Electrodes
Micro and Nanosystems Reversing Breast Cancer Stem Cell into Breast Somatic Stem Cell
Current Pharmaceutical Biotechnology Effects of Vitamin C and E Against Oxidative Stress: Is Antioxidant Supplementation Efficient?
Current Nutraceuticals Homocysteine and Heart Failure: An Overview
Recent Patents on Cardiovascular Drug Discovery Cognitive Impairment and Diabetes
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Toll-like Receptors as a Novel Therapeutic Target for Natural Products Against Chronic Diseases
Current Drug Targets Editorial: Advances in Alzheimer Therapy: Something Old, Something New, Something Borrowed, Something Blue
Current Alzheimer Research Pleiotropic Effects of Statin in Therapy in Heart Failure: A Review
Current Vascular Pharmacology Myocardial Infarction. Pathological Relevance and Relationship with Coronary Risk Factors
Current Pharmaceutical Design Uric Acid and Diabetes: Is there a Link?
Current Pharmaceutical Design Inappropriate Medication Use and Cost Comparison Analysis of Proton Pump Inhibitors: Evidence from an Indian Tertiary Care Facility
Current Drug Safety Effect of Depression on Self-Management Behaviors and Health Outcomes in Adults with Type 2 Diabetes
Current Diabetes Reviews Caffeine and Suicide: A Systematic Review
CNS & Neurological Disorders - Drug Targets Lipoprotein Subfractions, Uric Acid and Cardiovascular Risk in End-Stage Renal Disease (ESRD) Patients
Current Vascular Pharmacology Dendritic Cell Endothelium Interaction in Autoimmunity
Current Pharmaceutical Design